CollPlant Biotechnologies Future Growth
Future criteria checks 2/6
CollPlant Biotechnologies is forecast to grow earnings and revenue by 57.6% and 28.5% per annum respectively while EPS is expected to grow by 56.2% per annum.
Key information
57.6%
Earnings growth rate
56.2%
EPS growth rate
Biotechs earnings growth | 24.6% |
Revenue growth rate | 28.5% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 30 May 2024 |
Recent future growth updates
Recent updates
We're Interested To See How CollPlant Biotechnologies (NASDAQ:CLGN) Uses Its Cash Hoard To Grow
Feb 03Is CollPlant Biotechnologies (NASDAQ:CLGN) In A Good Position To Deliver On Growth Plans?
Nov 02CollPlant Biotechnologies Ltd.'s (NASDAQ:CLGN) Shares Lagging The Industry But So Is The Business
Sep 06Here's Why We're Watching CollPlant Biotechnologies' (NASDAQ:CLGN) Cash Burn Situation
Jul 14Here's Why We're Not Too Worried About CollPlant Biotechnologies' (NASDAQ:CLGN) Cash Burn Situation
Mar 02Companies Like CollPlant Biotechnologies (NASDAQ:CLGN) Are In A Position To Invest In Growth
Nov 10CollPlant Non-GAAP EPS of -$0.36, revenue of $0.07M
Aug 25We Think CollPlant Biotechnologies (NASDAQ:CLGN) Can Afford To Drive Business Growth
Jul 22CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year
Aug 22CollPlant Biotechnologies - A Cheap, Game-Changing Bio-Printing Platform Company
Aug 05Why We Think Shareholders May Be Considering Bumping Up CollPlant Biotechnologies Ltd.'s (NASDAQ:CLGN) CEO Compensation
Jul 29The Strong Earnings Posted By CollPlant Biotechnologies (NASDAQ:CLGN) Are A Good Indication Of The Strength Of The Business
Jun 09Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 22 | 0 | N/A | N/A | 1 |
12/31/2025 | 15 | -6 | N/A | N/A | 1 |
12/31/2024 | 3 | -17 | N/A | N/A | 1 |
12/31/2023 | 11 | -7 | -4 | -3 | N/A |
9/30/2023 | 11 | -7 | -5 | -4 | N/A |
6/30/2023 | 11 | -7 | -15 | -14 | N/A |
3/31/2023 | 1 | -17 | -15 | -14 | N/A |
12/31/2022 | 0 | -17 | -15 | -14 | N/A |
9/30/2022 | 1 | -16 | -14 | -13 | N/A |
6/30/2022 | 1 | -15 | -14 | -12 | N/A |
3/31/2022 | 1 | -14 | -14 | -12 | N/A |
12/31/2021 | 16 | 0 | 1 | 3 | N/A |
9/30/2021 | 16 | 1 | 2 | 3 | N/A |
6/30/2021 | 20 | 5 | 7 | 8 | N/A |
3/31/2021 | 20 | 6 | 9 | 9 | N/A |
12/31/2020 | 6 | -6 | -5 | -4 | N/A |
9/30/2020 | 6 | -7 | -5 | -4 | N/A |
6/30/2020 | 3 | -11 | -8 | -7 | N/A |
3/31/2020 | 2 | -11 | -8 | -7 | N/A |
12/31/2019 | 2 | -11 | -7 | -6 | N/A |
9/30/2019 | 6 | -6 | -2 | -1 | N/A |
6/30/2019 | 6 | -6 | -2 | -1 | N/A |
3/31/2019 | 5 | -4 | -2 | -1 | N/A |
12/31/2018 | 5 | -6 | -2 | -1 | N/A |
9/30/2018 | 1 | -6 | -7 | -6 | N/A |
6/30/2018 | 1 | -6 | -6 | -6 | N/A |
3/31/2018 | 1 | -7 | -5 | -5 | N/A |
12/31/2017 | 0 | -6 | -5 | -5 | N/A |
9/30/2017 | 0 | -6 | N/A | -5 | N/A |
6/30/2017 | 0 | -7 | N/A | -5 | N/A |
3/31/2017 | 0 | -7 | N/A | -5 | N/A |
12/31/2016 | 0 | -7 | N/A | -5 | N/A |
9/30/2016 | 0 | -7 | N/A | -5 | N/A |
6/30/2016 | N/A | -7 | N/A | -5 | N/A |
3/31/2016 | N/A | -6 | N/A | -5 | N/A |
12/31/2015 | N/A | -5 | N/A | -4 | N/A |
9/30/2015 | N/A | -4 | N/A | -4 | N/A |
6/30/2015 | N/A | -4 | N/A | -4 | N/A |
3/31/2015 | N/A | -3 | N/A | -3 | N/A |
12/31/2014 | N/A | -3 | N/A | -3 | N/A |
9/30/2014 | N/A | -4 | N/A | -4 | N/A |
6/30/2014 | N/A | -4 | N/A | -4 | N/A |
3/31/2014 | N/A | -4 | N/A | -4 | N/A |
12/31/2013 | N/A | -5 | N/A | -4 | N/A |
9/30/2013 | N/A | -5 | N/A | -3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CLGN is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: CLGN is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: CLGN is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: CLGN's revenue (28.5% per year) is forecast to grow faster than the US market (8.4% per year).
High Growth Revenue: CLGN's revenue (28.5% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if CLGN's Return on Equity is forecast to be high in 3 years time